8 unchanged sentences
Any determination to pay dividends would be at the discretion of our board of directors and would depend on our results of operation, financial condition and other factors that our board of directors, in its discretion, considers relevant .
−Removed: Use of Proceeds from Registered Securities
−Removed: To date, we have used $190.8 million of the net proceeds from sales of our common stock, of which, $4.5 million was used for contributions to FF Gene Biotech prior to the FF Gene Biotech Acquisition, $170.5 million was used to fund the Company’s operation and a business combination, and $15.8 million was used to pay off the investment margin loan.
−Removed: All other net proceeds from sales of our common stock are invested in investment-grade and interest-bearing securities, such as corporate bonds, municipal bonds, and U.S.
−Removed: government and U.S.
−Removed: agency debt securities.
−Removed: There has been no material change in the planned use of proceeds from the sales of our common stock from that described in the Prospectus.
Common Stock Performance Graph
−Removed: The following graph compares the cumulative total stockholder return, calculated on a dividend-reinvested basis, in Fulgent's Common Stock, the Nasdaq Composite Index, and the Nasdaq Biotechnology Index for the five years ended December 31, 2024.
−Removed: The comparison assumes that $100 was invested in the Company’s common stock, the NASDAQ Composite Index, and the Nasdaq Biotechnology Index as of the market close on December 31, 2019.
+Added: The following graph compares the cumulative total stockholder return, calculated on a dividend-reinvested basis, in our common stock, the Nasdaq Composite Index, and the Nasdaq Biotechnology Index for the five years ended December 31, 2025.
+Added: The comparison assumes that $100 was invested in our common stock, the NASDAQ Composite Index, and the Nasdaq Biotechnology Index as of the market close on December 31, 2020.
Note that historic stock price performance is not necessarily indicative of future stock price performance.
Information on Share Repurchases
−Removed: The number of shares of common stock repurchased by the Company during the year ended December 31, 2024 and the average price paid per share are as follows:
−Removed: (a) Total Number of Shares Purchased
−Removed: (b) Average Price Paid Per Share (1)
−Removed: (c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
−Removed: (d) Maximum Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
−Removed: March 2024 (3/1/2024-3/31/2024)
−Removed: (1) Includes commissions for the shares repurchased under the stock repurchase program.
+Added: There were no shares of common stock purchased during the three months ended December 31, 2025.
+Added: For further information about shares repurchased, see Note 16, Stock Repurchase Program , to our consolidated financial statements.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.